New Insights Into the Use of Biomarkers of Diabetic Nephropathy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Roglic, 2005, The burden of mortality attributable to diabetes: realistic estimates for the year 2000, Diabetes Care, 28, 2130, 10.2337/diacare.28.9.2130
Molitch, 2004, Nephropathy in diabetes, Diabetes Care, 27, S79
Cooper, 1998, Pathogenesis, prevention, and treatment of diabetic nephropathy, Lancet, 352, 213, 10.1016/S0140-6736(98)01346-4
Brenner, 1978, Molecular basis of proteinuria of glomerular origin, N Engl J Med, 298, 826, 10.1056/NEJM197804132981507
Forbes, 2008, Oxidative stress as a major culprit in kidney disease in diabetes, Diabetes, 57, 1446, 10.2337/db08-0057
Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a
Kaneto, 2007, Involvement of oxidative stress in the pathogenesis of diabetes, Antioxid Redox Signal, 9, 355, 10.1089/ars.2006.1465
Palicz, 2001, Phosphatidic acid and diacylglycerol directly activate NADPH oxidase by interacting with enzyme components, J Biol Chem, 276, 3090, 10.1074/jbc.M007759200
Moresco, 2013, Diabetic nephropathy: traditional to proteomic markers, Clin Chim Acta, 421, 17, 10.1016/j.cca.2013.02.019
Keane, 1999, Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation, Am J Kidney Dis, 33, 1004, 10.1016/S0272-6386(99)70442-7
Perkins, 2010, In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria, Kidney Int, 77, 57, 10.1038/ki.2009.399
Adler, 2003, Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64), Kidney Int, 63, 225, 10.1046/j.1523-1755.2003.00712.x
Yokoyama, 2012, Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25), Diabetologia, 55, 1911, 10.1007/s00125-012-2536-y
Cohen-Bucay, 2012, Urinary markers of glomerular injury in diabetic nephropathy, Int J Nephrol, 2012, 146987, 10.1155/2012/146987
Macisaac, 2006, Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods, Diabetologia, 49, 1686, 10.1007/s00125-006-0275-7
Kanauchi, 2002, Transferrinuria in type 2 diabetic patients with early nephropathy and tubulointerstitial injury, Eur J Intern Med, 13, 190, 10.1016/S0953-6205(02)00028-6
Jerums, 1987, Spectrum of proteinuria in type I and type II diabetes, Diabetes Care, 10, 419, 10.2337/diacare.10.4.419
Jerums, 1989, Triphasic changes in selectivity with increasing proteinuria in type 1 and type 2 diabetes, Diabet Med, 6, 772, 10.1111/j.1464-5491.1989.tb01277.x
Yaqoob, 1995, Tubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathy, Ren Fail, 17, 43, 10.3109/08860229509036374
von Eynatten, 2009, Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes, Diabetes, 58, 2093, 10.2337/db09-0204
Saraheimo, 2008, Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes, Diabetes Care, 31, 1165, 10.2337/dc07-2306
Sharma, 2008, Adiponectin regulates albuminuria and podocyte function in mice, J Clin Invest, 118, 1645
Narita, 2004, Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients, Diabetes Care, 27, 1176, 10.2337/diacare.27.5.1176
Narita, 2006, Increased urinary excretions of immunoglobulin G, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes, Diabetes Care, 29, 142, 10.2337/diacare.29.01.06.dc05-1063
Qin, 2004, Zhong Nan Da Xue Xue Bao Yi Xue Ban, 29, 208
Hong, 1998, Markers of diabetic nephropathy, J Diabetes Complications, 12, 43, 10.1016/S1056-8727(97)00045-7
Inoue, 2008, Rinsho Byori, 56, 564
Nakamura, 2000, Urinary excretion of podocytes in patients with diabetic nephropathy, Nephrol Dial Transplant, 15, 1379, 10.1093/ndt/15.9.1379
Wang, 2007, Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy, Nephron Clin Pract, 106, c169, 10.1159/000104428
Hara, 2012, Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin, Diabetologia, 55, 2913, 10.1007/s00125-012-2661-7
Nielsen, 2009, The role of podocalyxin in health and disease, J Am Soc Nephrol, 20, 1669, 10.1681/ASN.2008070782
Koop, 2003, Expression of podocyte-associated molecules in acquired human kidney diseases, J Am Soc Nephrol, 14, 2063, 10.1097/01.ASN.0000078803.53165.C9
Mishra, 2003, Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury, J Am Soc Nephrol, 14, 2534, 10.1097/01.ASN.0000088027.54400.C6
Nielsen, 2010, Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril, Diabetic Med, 27, 1144, 10.1111/j.1464-5491.2010.03083.x
Nielsen, 2012, Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients, Diabetes Res Clin Pract, 97, 71, 10.1016/j.diabres.2012.02.007
Piwowar, 2006, Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus, Med Sci Monit, 12, CR210
Vaidya, 2011, Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-beta-D-glucosaminidase, Kidney Int, 79, 464, 10.1038/ki.2010.404
Vaidya, 2008, Biomarkers of acute kidney injury, Annu Rev Pharmacol Toxicol, 48, 463, 10.1146/annurev.pharmtox.48.113006.094615
Tesch, 2010, Review: serum and urine biomarkers of kidney disease: a pathophysiological perspective, Nephrology (Carlton), 15, 609, 10.1111/j.1440-1797.2010.01361.x
Nielsen, 2011, Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy, Kidney Int, 79, 1113, 10.1038/ki.2010.554
Ekstrom, 1975, A urinary and plasma alpha1-glycoprotein of low molecular weight: isolation and some properties, Biochem Biophys Res Commun, 65, 1427, 10.1016/S0006-291X(75)80388-3
Hong, 2003, Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore, Diabetes Care, 26, 338, 10.2337/diacare.26.2.338
Yoshikawa, 2007, Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients, Diabetes Res Clin Pract, 76, 358, 10.1016/j.diabres.2006.09.004
Helaly, 2007, Endothelial dysfunction in geriatric diabetic patients: the role of microalbuminuria in elderly type 2 diabetic patients? A randomized controlled study, Int Urol Nephrol, 39, 333, 10.1007/s11255-006-9103-8
Portilla, 2008, Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery, Kidney Int, 73, 465, 10.1038/sj.ki.5002721
Nielsen, 2009, Tubular and glomerular injury in diabetes and the impact of ACE inhibition, Diabetes Care, 32, 1684, 10.2337/dc09-0429
Ishimitsu, 2005, Urinary excretion of liver fatty acid-binding protein in health-check participants, Clin Exp Nephrol, 9, 34, 10.1007/s10157-004-0331-x
Panduru, 2013, Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes, Diabetes Care, 36, 2077, 10.2337/dc12-1868
Nauta, 2011, Glomerular and tubular damage markers are elevated in patients with diabetes, Diabetes Care, 34, 975, 10.2337/dc10-1545
Lisowska-Myjak, 2010, Serum and urinary biomarkers of acute kidney injury, Blood Purif, 29, 357, 10.1159/000309421
Hong, 2000, Urinary protein excretion in Type 2 diabetes with complications, J Diabetes Complications, 14, 259, 10.1016/S1056-8727(00)00119-7
Kado, 1996, Urinary type IV collagen as a marker for early diabetic nephropathy, Diabetes Res Clin Pract, 31, 103, 10.1016/0168-8227(96)01210-7
Iijima, 1998, Follow-up study on urinary type IV collagen in patients with early stage diabetic nephropathy, J Clin Lab Anal, 12, 378, 10.1002/(SICI)1098-2825(1998)12:6<378::AID-JCLA8>3.0.CO;2-J
Takizawa, 1998, Increase of urinary type IV collagen in normoalbuminuric patients with impaired glucose tolerance, Nephron, 79, 474, 10.1159/000045096
Cohen, 2001, Increased collagen IV excretion in diabetes. A marker of compromised filtration function, Diabetes Care, 24, 914, 10.2337/diacare.24.5.914
Tsakas, 2006, Accurate measurement and clinical significance of urinary transforming growth factor-beta1, Am J Nephrol, 26, 186, 10.1159/000093178
Wong, 2013, Circulating bone morphogenetic protein-7 and transforming growth factor-beta1 are better predictors of renal end points in patients with type 2 diabetes mellitus, Kidney Int, 83, 278, 10.1038/ki.2012.383
Wong, 2007, Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy, Clin Exp Immunol, 149, 123, 10.1111/j.1365-2249.2007.03389.x
Wada, 2000, Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy, Kidney Int, 58, 1492, 10.1046/j.1523-1755.2000.00311.x
Tashiro, 2002, Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy, J Clin Lab Anal, 16, 1, 10.1002/jcla.2057
Ortiz, 1995, Is there a role for specific anti-TNF strategies in glomerular diseases?, Nephrol Dial Transplant, 10, 309
Niewczas, 2009, Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes, Clin J Am Soc Nephrol, 4, 62, 10.2215/CJN.03010608
Navarro, 2008, Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients, Nephrol Dial Transplant, 23, 919, 10.1093/ndt/gfm674
Nakamura, 2005, Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes, Diabetes Care, 28, 2890, 10.2337/diacare.28.12.2890
Pickup, 2000, Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes, Life Sci, 67, 291, 10.1016/S0024-3205(00)00622-6
Navarro, 2006, Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients, Nephrol Dial Transplant, 21, 3428, 10.1093/ndt/gfl469
Dechanet, 1997, CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells, J Immunol, 159, 5640, 10.4049/jimmunol.159.11.5640
El-Asrar, 2012, Soluble CD40L in children and adolescents with type 1 diabetes: relation to microvascular complications and glycemic control, Pediatr Diabetes, 13, 616, 10.1111/j.1399-5448.2012.00881.x
Chiarelli, 2008, Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria, Diabetes Metab Res Rev, 24, 570, 10.1002/dmrr.891
Lajer, 2010, Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function, Platelets, 21, 525, 10.3109/09537104.2010.500422
Giacco, 2010, Oxidative stress and diabetic complications, Circ Res, 107, 1058, 10.1161/CIRCRESAHA.110.223545
Oberg, 2004, Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease, Kidney Int, 65, 1009, 10.1111/j.1523-1755.2004.00465.x
Wu, 2004, Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics, Clin Chim Acta, 339, 1, 10.1016/j.cccn.2003.09.010
Kanauchi, 2002, Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy, Nephron, 91, 327, 10.1159/000058412
Calabrese, 2007, Oxidative stress and cellular stress response in diabetic nephropathy, Cell Stress Chaperones, 12, 299, 10.1379/CSC-270.1
Thuraisingham, 2000, Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy, Kidney Int, 57, 1968, 10.1046/j.1523-1755.2000.00046.x
Sugiyama, 1998, Plasma levels of pentosidine in diabetic patients: an advanced glycation end product, J Am Soc Nephrol, 9, 1681, 10.1681/ASN.V991681
Ben Ameur, 2010, Proteomic approaches for discovering biomarkers of diabetic nephropathy, Nephrol Dial Transplant, 25, 2866, 10.1093/ndt/gfq258
Thongboonkerd, 2011, Study of diabetic nephropathy in the proteomic era, Contrib Nephrol, 170, 172, 10.1159/000325657
Otu, 2007, Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy, Diabetes Care, 30, 638, 10.2337/dc06-1656
Starkey, 2012, Proteomics and systems biology for understanding diabetic nephropathy, J Cardiovasc Transl Res, 5, 479, 10.1007/s12265-012-9372-9
Merchant, 2009, Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria, J Am Soc Nephrol, 20, 2065, 10.1681/ASN.2008121233
Zurbig, 2012, Urinary proteomics for early diagnosis in diabetic nephropathy, Diabetes, 61, 3304, 10.2337/db12-0348
Roscioni, 2013, A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus, Diabetologia, 56, 259, 10.1007/s00125-012-2755-2
Bhensdadia, 2013, Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes, Kidney Int, 83, 1136, 10.1038/ki.2013.57
Lewis, 2008, Application of metabolomics to cardiovascular biomarker and pathway discovery, J Am Coll Cardiol, 52, 117, 10.1016/j.jacc.2008.03.043